Use of GLP-1 drugs is highest among adults who report being diagnosed with conditions these drugs are prescribed to treat, including those who have ever been told by a doctor that they have diabetes (57% ever used, including 45% currently using), heart disease (40% ever, 29% currently), and those that have been told by a doctor that they are overweight or obese in the past five years (34% ever, 23% currently)
Gesuete, V., Ragni, L., and Picchio, F
However, its promise demands rigorous, mechanistically grounded inquiry
Which companion products support proper handling of this peptide in the lab
Detailed Results 1 From January 1, 2022, to June 30, 2025, GLP-1 exposure was defined as first prescription prior to the breast imaging examination with documented outcome from the imaging